new_0222_0279|AKRO|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0279|AKRO|Long Name|1|1|Akero Therapeutics Inc Total Current Assets (Quarterly) (USD)|Akero Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Akero Therapeutics Inc Inventories (Quarterly) (USD)|Akero Therapeutics Inc Net PP&E (Quarterly) (USD)|Akero Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Akero Therapeutics Inc Total Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Akero Therapeutics Inc Total Deposits (Quarterly) (USD)|Akero Therapeutics Inc Book Value (Quarterly) (USD)|Akero Therapeutics Inc Retained Earnings (Quarterly) (USD)|Akero Therapeutics Inc Treasury Stock (Quarterly) (USD)|Akero Therapeutics Inc EV to Revenues|Akero Therapeutics Inc EV to Earnings|Akero Therapeutics Inc EV to Free Cash Flow|Akero Therapeutics Inc EV to Assets (Quarterly)|Akero Therapeutics Inc PS Ratio|Akero Therapeutics Inc PE Ratio|Akero Therapeutics Inc Price to Book Value|Akero Therapeutics Inc PEG Ratio|Akero Therapeutics Inc Debt to Equity Ratio|Akero Therapeutics Inc Dividend Yield|Akero Therapeutics Inc Shareholder Yield (TTM)|Akero Therapeutics Inc Percent of Shares Outstanding Short|Akero Therapeutics Inc Total Receivables (Quarterly) (USD)|Akero Therapeutics Inc Total Payables (Quarterly) (USD)|Akero Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Akero Therapeutics Inc Return on Invested Capital|Akero Therapeutics Inc Quality Ratio Score|Akero Therapeutics Inc Momentum Score|Akero Therapeutics Inc Beta (1Y)|Akero Therapeutics Inc Sustainable Growth Rate (TTM)|Akero Therapeutics Inc Institutional Investor Ownership Percentage|Akero Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Akero Therapeutics Inc Total Employees (Annual)|Akero Therapeutics Inc EPS Diluted (Quarterly) (USD)|Akero Therapeutics Inc SG&A Expense (Quarterly) (USD)|Akero Therapeutics Inc Shares Outstanding|Akero Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Akero Therapeutics Inc Ordinary Shares Number (Quarterly)|Akero Therapeutics Inc Payout Ratio|Akero Therapeutics Inc Quick Ratio (Quarterly)|Akero Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Akero Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Akero Therapeutics Inc Effective Tax Rate (TTM)|Akero Therapeutics Inc Return on Equity|Akero Therapeutics Inc Net Income (TTM) (USD)|Akero Therapeutics Inc Revenue (TTM) (USD)|Akero Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Akero Therapeutics Inc Revenue (Quarterly) (USD)|Akero Therapeutics Inc Gross Profit (Quarterly) (USD)|Akero Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Akero Therapeutics Inc Net Income (Quarterly) (USD)|Akero Therapeutics Inc Net Interest Income (Quarterly) (USD)|Akero Therapeutics Inc Price (USD)|Akero Therapeutics Inc Total Return Price (USD)|Akero Therapeutics Inc Enterprise Value (USD)|Akero Therapeutics Inc 30-Day Average Daily Volume|Akero Therapeutics Inc 1 Year Price Returns (Daily)|Akero Therapeutics Inc Short Interest|Akero Therapeutics Inc PE Ratio (Forward)|Akero Therapeutics Inc PE Ratio (Forward 1y)|Akero Therapeutics Inc PS Ratio (Forward)|Akero Therapeutics Inc PS Ratio (Forward 1y)|Akero Therapeutics Inc Quarterly EPS Estimates (USD)|Akero Therapeutics Inc Quarterly Revenue Estimates (USD)|Akero Therapeutics Inc Quarterly EPS Surprise|Akero Therapeutics Inc Quarterly Revenue Surprise|Akero Therapeutics Inc Quarterly Actual EPS (USD)|Akero Therapeutics Inc Quarterly Actual Revenue (USD)|Akero Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Akero Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Akero Therapeutics Inc Price Target (USD)|Akero Therapeutics Inc Consensus Recommendation|Akero Therapeutics Inc Price Target Num Estimates|Akero Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Akero Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Akero Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Akero Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Akero Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Akero Therapeutics Inc Land and Improvements (Quarterly) (USD)|Akero Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Akero Therapeutics Inc Other Properties (Quarterly) (USD)|Akero Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0279|AKRO|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0279|AKRO||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0279|AKRO||5|5|91.2727272727|91.2727272727|0|91.2857142857|0|91.2727272727|91.2727272727|91.2727272727|0|91.2727272727|91.2727272727|0|0|0|6.95714285714|0|0|0|6.95714285714|0|0|1.44725111441|0|15.2903225806|0|91.2727272727|91.2727272727|0|0|32.2941176471|30.5263157895|0|0|91.3571428571|100.4|91.3571428571|91.3571428571|36.7916666667|0|91.2727272727|0|0|91.3571428571|91.3846153846|0|0|91.2727272727|0|0|0|0|91.3571428571|91.3571428571|91.5|6.95714285714|6.95714285714|6.95714285714|6.9552238806|1.44285714286|15.2903225806|0|0|0|0|91.3333333333|91.3333333333|91.2857142857|0|91.2857142857|91.2857142857|31.8214285714|31.8214285714|21.8604651163|9.21568627451|21.8604651163|18.62|22.1666666667|91.3571428571|91.2857142857|0|0|0|91.3333333333|0
new_0222_0279|AKRO||6|6|11|11|0|7|0|11|11|11|0|11|11|0|0|0|140|0|0|0|140|0|0|673|0|62|0|11|11|0|0|17|19|0|0|14|10|14|14|24|0|11|0|0|14|13|0|0|11|0|0|0|0|14|14|2|140|140|140|134|420|62|0|0|0|0|12|12|7|0|7|7|28|28|43|102|43|50|42|14|7|0|0|0|6|0
new_0222_0279|AKRO||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0279|AKRO|201803|201803|201803||||||||||||||||||||||||||||||||||21.2242||-0.0198|0.195||||||-0.0198|||||||||-0.421|-0.421|||||||||||||||||||||||||0.226||||||
new_0222_0279|AKRO|201806|201806|201806||||||||||||||||||||||||||||||||||21.2242||-0.4119|0.242||||||-0.4086|0||||||||-8.673|-8.673|||||||||||||||||||||||||8.42||||||
new_0222_0279|AKRO|201809|201809|201809||||||||||||||||||||||||||||||||||21.2242||-0.5371|0.474||||||-0.5252|0||||||||-11.148|-11.148|||||||||||||||||||||||||1.253||||||
new_0222_0279|AKRO|201812|201812|201812|77.131|75.975||||127.07|2.342|124.728||-49.919|-86.565|||||||||||||||1.373|0|||||||21.2242|10|-2.9057|0.985|||26.2951|||-2.8963|0|||-81.714|||||-61.472|-61.472|||||||||||||||||||||||||1.983||||||
new_0222_0279|AKRO|201903|201903|201903|70.699|69.796||||2.404|2.404|0||69.662|-91.927|||||||||||||||0.952|0.002|||||||26.2951||-0.2039|1.449|||26.2951|||-0.2039||||-86.655|||||-5.362|-5.362|0.166||||||||||||||||||||||||4.063||||||
new_0222_0279|AKRO|201906|201906|201906|163.108|162.654||||4.779|4.74|0.039||158.389|-99.155||||-29.3368||||7.2056|||0||0.1952||3.248|0.003|||||||3.2684|10|-2.21|1.649|28.5554||28.5554|||-2.21|-97.08|||-85.21|||||-7.228|-7.228|0.381|18.56|18.56|432.1611|||52797||||||||||||||||||5.96||||||
new_0222_0279|AKRO|201907|201906|201906|||||||||||||||-39.401||||4.7091|||0||0.8404|||||||||||||||||||||||||||||||26.12|26.12|583.213|||239983|||||||||||0|0|31.25|1.5|4|-1.4903|-1.9711|||||||
new_0222_0279|AKRO|201908|201906|201906|||||||||||||||-46.6546||||4.9957|||0||0.9965||||||||||||||28.5554|||||||||||||||||27.71|27.71|628.6161|85686.8333||284551|||||||||||0|0|32|1.5|4|-2.4265|-2.2127|||||||
new_0222_0279|AKRO|201909|201909|201909|150.073|147.835||||6.759|6.725|0.034||143.384|-114.709||||-25.974||||3.5751|||0||1.7624||0.093|0.003|||||||28.0248|10|-0.56|2.424|28.5587||28.5587|||-0.56|1.628|||-89.616|||||-15.554|-15.554|0.755|19.83|19.83|403.5996|134419.5333||503304|||||||||||||32|1.5|4|||13.885||||||
new_0222_0279|AKRO|201910|201909|201909|||||||||||||||-19.9213||||4.1807|||0||1.8418|||||||||||||||||||||||||||||||20.99|20.99|451.6121|123273.1667||525988||||||||||||||||||||||||
new_0222_0279|AKRO|201911|201909|201909|||||||||||||||-15.3832||||3.9218|||0||1.8275||||||||||||||28.5587|||||||||||||||||19.69|19.69|414.4858|71951.6333||521908|||||||||||0|0|32|1.5|4|-2.6864|-2.2809|||||||
new_0222_0279|AKRO|201912|201912|201912|138.049|136.4||0||9.392|9.369|0.023||128.726|-130.32||||-19.0444||||4.597|||0||2.3448||0.947|0.003|||||||28.5678|14|-0.55|3.083|28.5678||28.5678|||-0.55|0|||-43.755|||||-15.611|-15.611||23.08|23.08|511.2998|133689.6667||669870|||||-0.5849|0|5.9733||-0.55|0|0|||1.5||-2.7411||13.138|0|||||
new_0222_0279|AKRO|202001|201912|201912|||||||||||||||-16.1377||||5.4794|||0||2.096|||||||||||||||||||||||||||||||24.69|24.69|568.939|231118.6||598780||||||||||||||1.5||||||||||
new_0222_0279|AKRO|202002|201912|201912|||||||||||||||-13.8043||||4.8314|||0||2.3854|||||||||||||||||||||||||||||||21.77|21.77|485.521|167293.9333||681450|||||||||||0|0|34.6|1.4|5|||||||||
new_0222_0279|AKRO|202003|202003|202003|126.218|125.285||0.226||8.298|8.286|0.012||118.323|-142.206||||-9.79||||3.7181|||0||2.8556||1.535|0.003|||||||28.4995|14|-0.42|3.588|28.6712||28.6712|||-0.42||||-50.279|||||-11.886|-11.886||16.73|16.73|342.2102|239636.8||818733|||||-0.61|0|31.1475||-0.42|0|0|0|34.3333|1.5|6|-2.37|-2.688|8.791|0||||0.226|
new_0222_0279|AKRO|202004|202003|202003|||||||||||||||-11.0749||||5.2097|||0||4.1018||||||||||||||28.6712|||||||||||||||||21.5|21.5|491.1458|232628.9||1176041||||||||||||||1.5||||||||||
new_0222_0279|AKRO|202005|202003|202003|||||||||||||||-14.2958||||6.0414|||0||1.9854||||||||||||||28.6736|||||||||||||||||24.93|24.93|589.5478|170600.6333||569275|||||||||||||34.3333|1.5|6|-1.8305|-2.5739|||||||
new_0222_0279|AKRO|202006|202006|202006|113.193|102.833||||10.395|10.393|0.002||103.663|-158.413||||-14.4063||||5.942|||0||3.9039||2.536|0.003||||0.3033|||28.603|13|-0.57|3.417|28.6837||28.6837|||-0.57||||-59.258|||||-16.207|-16.207||24.52|24.52|577.7917|230644.5333|30.1305|1119768|||||-0.6177|0|7.7252||-0.57|0|0|0|32.6|1.4|5|-1.8674|-2.6699|13.037|0|||||
new_0222_0279|AKRO|202007|202006|202006|||||||||||||||-19.5771||||12.7421|||0||2.3236||||||9|0.6425|||||||34.6961|||||||||||||||||36.12|36.12|1218.0475|560726.5|45.0826|806181|||||||||||0|0|60.1667|1.3333|6|-2.8304|-2.6774|||||||
new_0222_0279|AKRO|202008|202006|202006|||||||||||||||-16.9403||||10.9127|||0||2.7458||||||9|0.5575|||||||34.7008|||||||||||||||||31.65|31.65|1028.4131|200357.7|17.6471|952831|||||||||||0|0|60.8333|1.3333|6|-2.8887|-2.6864|||||||
new_0222_0279|AKRO|202009|202009|202009|298.033|291.87||1.847||13.578|12.014|1.564||286.458|-179.816||||-17.2356||||10.501|||0||3.9085||4.636|0.004|||7|0.6269|||34.0028|17|-0.63|4.159|34.7207||34.7207|||-0.63|-202.554|||-65.107|||||-21.403|-21.403||32.15|32.15|985.7311|162215.5|35.3407|1357060|||||-0.671|0|6.1103||-0.63|0|0|0|62.1429|1.4286|7|-2.6966|-2.4839|17.379|0.006||||1.847|
new_0222_0279|AKRO|202010|202009|202009|||||||||||||||-10.6118||||3.1829|||0||4.405||||||8|0.7346||||||||||||||||||||||||26.5|26.5|619.8956|186136.9333|13.7045|1529440|||||||||||||60|1.4286|7|||||||||
new_0222_0279|AKRO|202011|202009|202009|||||||||||||||-12.2134||||3.4315|||0||5.2002||||||7|0.7801|||||||34.7218|||||||||||||||||29.23|29.23|691.1042|175283.4|46.1656|1805598|||||||||||0|0|60.2857|1.4286|7|-2.2016|-2.7297|||||||
new_0222_0279|AKRO|202012|202012|202012|271.345|268.387||1.793||14.627|13.111|1.516||258.712|-209.527||||-10.102||||3.0448|||0||7.2844||3.428|0.004|||8|0.7065|||34.708|21|-0.86|4.074|34.7416||34.7416|||-0.86|0|||-79.207|||||-29.711|-29.711||25.63|25.63|580.3416|223375.2333|16.2424|2530734|||||-0.5955|0|-44.4092||-0.86|0|0|0||1.4286||-2.2161||25.709|0.011||||1.793|
new_0222_0279|AKRO|202101|202012|202012|||||||||||||||-10.9117||||4.0299|||0||7.056||||||6|0.6762||||||||||||||||||||||||30.01|30.01|774.2084|344870.1667|23.0962|2451362|||||||||||||60.2857|1.4286|7|||||||||
new_0222_0279|AKRO|202102|202012|202012|||||||||||||||-11.039||||4.0649|||0||6.4058||||||6|0.5147||||||||||||||||||||||||30.27|30.27|783.2412|261093.6333|37.1222|2225478|||||||||||0|0|59.5|1.375|8|-2.6814|-2.6504|||||||
new_0222_0279|AKRO|202103|202103|202103|255.776|249.984||1.732||11.603|10.136|1.467||246.02|-224.617||||-10.1349||||3.8169|||0||8.2557||4.605|0.004|||6|0.5688|||34.7443|21|-0.43|4.526|34.7703||34.7703|||-0.43||||-82.411|||||-15.09|-15.09||28.4|28.4|719.0895|277597.1|36.8396|2870517|||||-0.936|0|54.0608||-0.43|0|0|0|60.125|1.375|8|-4.2104|-4.5851|10.602|0.011||||1.732|
new_0222_0279|AKRO|202104|202103|202103|||||||||||||||-10.5359||||4.3494|||0||9.8743||||||6|1.2045|||||||34.8203|||||||||||||||||30.73|30.73|820.0438|291579.2|50.9804|3438253|||||||||||||60.125|1.375|8|||||||||
new_0222_0279|AKRO|202105|202103|202103|||||||||||||||-8.301||||3.6423|||0||9.9238|||||||1.2221|||||||34.8261|||||||||||||||||25.73|25.73|646.0916|229757.2|4.4693|3456059|||||||||||0||60.25|1.375|8|-3.0616|-3.429|||||||
new_0222_0279|AKRO|202106|202106|202106|236.222|230.028||1.672||17.876|16.459|1.417||220.133|-253.55||||-8.2473||||3.6253|||0||9.8688||2.307|0.004|||3|1.2305|||34.8146|28|-0.83|4.99|34.8408||34.8408|||-0.83||||-95.137|||||-28.933|-28.933||25.61|25.61|641.9124|269973.3|-0.4414|3438361|||||-0.7056|0|-17.6221||-0.83|0||||1.375||||23.976|0.01||||1.672|
new_0222_0279|AKRO|202107|202106|202106|||||||||||||||-6.8484||||3.387|||0||10.6417||||||2|0.6815||||||||||||||||||||||||21.4|21.4|515.5651|250460.5667|-40.6423|3707647|||||||||||0|0|57.1429|1.4286|7|-2.9139|-3.0347|||||||
new_0222_0279|AKRO|202108|202106|202106|||||||||||||||-7.938||||3.7596|||0||8.3501||||||2|0.931|||||||34.8619|||||||||||||||||23.74|23.74|597.5935|220285.9333|-27.1779|2910997|||||||||||0|0|56.7143|1.4286|7|-3.2222|-3.5775|||||||
new_0222_0279|AKRO|202109|202109|202109|221.807|215.081||1.612||24.905|23.54|1.365||198.628|-277.88||||-7.6231||||3.652|||0||7.9869||6.784|0.004|||2|0.9009|||34.8621|32|-0.7|4.883|34.8753||34.8753|||-0.7|0|||-98.064|||||-24.33|-24.33||23.06|23.06|573.8874|176796.1333|-27.4115|2785447|||||-0.9068|0|22.8038||-0.7|0|0|0|54.7143|1.4286|7|-3.1842|-3.6455|19.47|0.009||||1.612|
new_0222_0279|AKRO|202110|202109|202109|||||||||||||||-7.0283||||3.7855|||0||7.6951||||||2|0.5164||||||||||||||||||||||||21.56|21.56|536.8305|141358.8|-18.9057|2683674|||||||||||||47|1.6667|6|-3.1842||||||||
new_0222_0279|AKRO|202111|202109|202109|||||||||||||||-6.895||||3.7342|||0||10.0839||||||2|0.0026|||||||34.8883|||||||||||||||||21.26|21.26|526.6443|184397.3|-26.1293|3518103|||||||||||0|0|47.5|1.6667|6|-2.7575|-3.1972|||||||
new_0222_0279|AKRO|202112|202112|202112|||||||||||||||-6.863||||3.7219|||0||10.8789||||||3|0.1588||||||||||||||||||||||||21.19|21.19|524.2021|221096.4|-18.0233|3795449|||||-0.8083|0|||||0|0|47|1.6667|6|-2.7575||||||||
new_0222_0279|AKRO|202201|202112|202112|||||||||||||||-4.6933||||3.4497|||0||9.6347||||||3|1.1173||||||||||||||||||||||||19.64|19.64|470.1252|191258.5333|-40.4487|3361367|||||||||||||46.5|1.6667|6|-3.1972|-3.5396|||||||
new_0222_0279|AKRO|202202|202112|202112|||||||||||||||-5.2871||||3.116|||0|||||||||||||||||||||||||||||||||17.74|17.74|403.8374|194184.3667|-43.4131||||||||||||||46.5|1.6667|6|||||||||
new_0222_0279|AKRO|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.835|0||||||||||||||||||
new_0222_0279|AKRO|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.865|0||||||||||||||||||
new_0222_0279|AKRO|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.84|0||||||||||||||||||
new_0222_0279|AKRO|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.8|0||||||||||||||||||